Review



ifnβ 8234 mb  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems ifnβ 8234 mb
    Ifnβ 8234 Mb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 93 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ifn%CE%B2+8234+mb/Recombinant+Mouse+IFN-beta+Protein/bio_rxiv__64898__2026__03__12__711356-253-0-4
    Average 95 stars, based on 93 article reviews
    ifnβ 8234 mb - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    other:

    Article Title: Defensive lipid droplets are PUFA reservoirs driving bacterial clearance and inflammation
    Article Snippet: IFNβ (8234-MB) was from R&D Systems (Minneapolis, MN, USA).



    Similar Products

    99
    InvivoGen ifnβ r d systems 8234 mb pam3csk4 invivogen tlrl
    Ifnβ R D Systems 8234 Mb Pam3csk4 Invivogen Tlrl, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ifn%CE%B2+8234+mb/Pam3CSK4/pm42747966-334-21-26
    Average 99 stars, based on 1 article reviews
    ifnβ r d systems 8234 mb pam3csk4 invivogen tlrl - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    95
    R&D Systems ifnβ 8234 mb
    Ifnβ 8234 Mb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ifn%CE%B2+8234+mb/Recombinant+Mouse+IFN-beta+Protein/bio_rxiv__64898__2026__03__12__711356-253-0-4
    Average 95 stars, based on 1 article reviews
    ifnβ 8234 mb - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems ifnβ
    ( A ) IFNγ supplementation in rPR8-H3N2-infected pups alters shedding dynamics . C57BL/6J (WT) or IFNγ⁻/⁻ index pups <t>were</t> <t>intranasally</t> infected with 300 PFU of rPR8-H3N2 and cohoused with uninfected contacts for 4 days. Index pups received intranasal IFNγ supplementation (1 ng/μL) or vehicle control beginning 4–6 hours post-infection and daily thereafter. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. ( B ) IFNγ-dependent transcriptional responses in the URT . Expression of selected antiviral and inflammatory genes in URT cellular fractions was quantified by qRT–PCR at 4 dpi. ( C ) IFNγ restores mucus production in IFNγ⁻/⁻ mice . URT secretions from IFNγ⁻/⁻ pups infected with rPR8-H3N2 and treated intranasally with IFNγ or vehicle control were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. ( D ) IFNγ induces mucus secretion in the absence of infection . URT secretions from uninfected pups treated intranasally with escalating doses of IFNγ (10 ng/μL, 1 ng/μL, 0.1 ng/μL) or vehicle, as well as from rPR8-H3N2-infected pups, were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. Statistical differences among groups were assessed using the Kruskal–Wallis test. ( E ) IFNγ enhances shedding during rPR8-H1 infection . Index pups infected with 300 PFU of rPR8-H1 received intranasal IFNγ (1 ng/μL/g), <t>IFNβ</t> (1 ng/μL/g) or vehicle beginning 4–6 hpi. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. Statistics . Differences between two groups were analyzed using the Mann–Whitney test. Differences among multi-group medians were analyzed by Kruskal–Wallis test. Experiments represent ≥2 independent biological replicates. Significance is denoted as *P < 0.05. Cartoons created with BioRender.com; graphs generated using GraphPad Prism 10.
    Ifnβ, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ifn%CE%B2+8234+mb/Recombinant+Mouse+IFN-beta+Protein/bio_rxiv__64898__2026__01__06__698034-190-14-15
    Average 95 stars, based on 1 article reviews
    ifnβ - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems recombinant mouse ifnβ
    ( A ) IFNγ supplementation in rPR8-H3N2-infected pups alters shedding dynamics . C57BL/6J (WT) or IFNγ⁻/⁻ index pups <t>were</t> <t>intranasally</t> infected with 300 PFU of rPR8-H3N2 and cohoused with uninfected contacts for 4 days. Index pups received intranasal IFNγ supplementation (1 ng/μL) or vehicle control beginning 4–6 hours post-infection and daily thereafter. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. ( B ) IFNγ-dependent transcriptional responses in the URT . Expression of selected antiviral and inflammatory genes in URT cellular fractions was quantified by qRT–PCR at 4 dpi. ( C ) IFNγ restores mucus production in IFNγ⁻/⁻ mice . URT secretions from IFNγ⁻/⁻ pups infected with rPR8-H3N2 and treated intranasally with IFNγ or vehicle control were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. ( D ) IFNγ induces mucus secretion in the absence of infection . URT secretions from uninfected pups treated intranasally with escalating doses of IFNγ (10 ng/μL, 1 ng/μL, 0.1 ng/μL) or vehicle, as well as from rPR8-H3N2-infected pups, were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. Statistical differences among groups were assessed using the Kruskal–Wallis test. ( E ) IFNγ enhances shedding during rPR8-H1 infection . Index pups infected with 300 PFU of rPR8-H1 received intranasal IFNγ (1 ng/μL/g), <t>IFNβ</t> (1 ng/μL/g) or vehicle beginning 4–6 hpi. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. Statistics . Differences between two groups were analyzed using the Mann–Whitney test. Differences among multi-group medians were analyzed by Kruskal–Wallis test. Experiments represent ≥2 independent biological replicates. Significance is denoted as *P < 0.05. Cartoons created with BioRender.com; graphs generated using GraphPad Prism 10.
    Recombinant Mouse Ifnβ, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ifn%CE%B2+8234+mb/Recombinant+Mouse+IFN-beta+Protein/pm40562879-338-0-7
    Average 95 stars, based on 1 article reviews
    recombinant mouse ifnβ - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems murine ifnβ 8234 mb
    ( A ) IFNγ supplementation in rPR8-H3N2-infected pups alters shedding dynamics . C57BL/6J (WT) or IFNγ⁻/⁻ index pups <t>were</t> <t>intranasally</t> infected with 300 PFU of rPR8-H3N2 and cohoused with uninfected contacts for 4 days. Index pups received intranasal IFNγ supplementation (1 ng/μL) or vehicle control beginning 4–6 hours post-infection and daily thereafter. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. ( B ) IFNγ-dependent transcriptional responses in the URT . Expression of selected antiviral and inflammatory genes in URT cellular fractions was quantified by qRT–PCR at 4 dpi. ( C ) IFNγ restores mucus production in IFNγ⁻/⁻ mice . URT secretions from IFNγ⁻/⁻ pups infected with rPR8-H3N2 and treated intranasally with IFNγ or vehicle control were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. ( D ) IFNγ induces mucus secretion in the absence of infection . URT secretions from uninfected pups treated intranasally with escalating doses of IFNγ (10 ng/μL, 1 ng/μL, 0.1 ng/μL) or vehicle, as well as from rPR8-H3N2-infected pups, were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. Statistical differences among groups were assessed using the Kruskal–Wallis test. ( E ) IFNγ enhances shedding during rPR8-H1 infection . Index pups infected with 300 PFU of rPR8-H1 received intranasal IFNγ (1 ng/μL/g), <t>IFNβ</t> (1 ng/μL/g) or vehicle beginning 4–6 hpi. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. Statistics . Differences between two groups were analyzed using the Mann–Whitney test. Differences among multi-group medians were analyzed by Kruskal–Wallis test. Experiments represent ≥2 independent biological replicates. Significance is denoted as *P < 0.05. Cartoons created with BioRender.com; graphs generated using GraphPad Prism 10.
    Murine Ifnβ 8234 Mb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ifn%CE%B2+8234+mb/Recombinant+Mouse+IFN-beta+Protein/pm38866307-38-0-6
    Average 95 stars, based on 1 article reviews
    murine ifnβ 8234 mb - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) IFNγ supplementation in rPR8-H3N2-infected pups alters shedding dynamics . C57BL/6J (WT) or IFNγ⁻/⁻ index pups were intranasally infected with 300 PFU of rPR8-H3N2 and cohoused with uninfected contacts for 4 days. Index pups received intranasal IFNγ supplementation (1 ng/μL) or vehicle control beginning 4–6 hours post-infection and daily thereafter. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. ( B ) IFNγ-dependent transcriptional responses in the URT . Expression of selected antiviral and inflammatory genes in URT cellular fractions was quantified by qRT–PCR at 4 dpi. ( C ) IFNγ restores mucus production in IFNγ⁻/⁻ mice . URT secretions from IFNγ⁻/⁻ pups infected with rPR8-H3N2 and treated intranasally with IFNγ or vehicle control were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. ( D ) IFNγ induces mucus secretion in the absence of infection . URT secretions from uninfected pups treated intranasally with escalating doses of IFNγ (10 ng/μL, 1 ng/μL, 0.1 ng/μL) or vehicle, as well as from rPR8-H3N2-infected pups, were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. Statistical differences among groups were assessed using the Kruskal–Wallis test. ( E ) IFNγ enhances shedding during rPR8-H1 infection . Index pups infected with 300 PFU of rPR8-H1 received intranasal IFNγ (1 ng/μL/g), IFNβ (1 ng/μL/g) or vehicle beginning 4–6 hpi. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. Statistics . Differences between two groups were analyzed using the Mann–Whitney test. Differences among multi-group medians were analyzed by Kruskal–Wallis test. Experiments represent ≥2 independent biological replicates. Significance is denoted as *P < 0.05. Cartoons created with BioRender.com; graphs generated using GraphPad Prism 10.

    Journal: bioRxiv

    Article Title: IFNγ-Driven Inflammatory Responses in the Nasal Mucosa Drive Influenza Virus Shedding and Transmission

    doi: 10.64898/2026.01.06.698034

    Figure Lengend Snippet: ( A ) IFNγ supplementation in rPR8-H3N2-infected pups alters shedding dynamics . C57BL/6J (WT) or IFNγ⁻/⁻ index pups were intranasally infected with 300 PFU of rPR8-H3N2 and cohoused with uninfected contacts for 4 days. Index pups received intranasal IFNγ supplementation (1 ng/μL) or vehicle control beginning 4–6 hours post-infection and daily thereafter. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. ( B ) IFNγ-dependent transcriptional responses in the URT . Expression of selected antiviral and inflammatory genes in URT cellular fractions was quantified by qRT–PCR at 4 dpi. ( C ) IFNγ restores mucus production in IFNγ⁻/⁻ mice . URT secretions from IFNγ⁻/⁻ pups infected with rPR8-H3N2 and treated intranasally with IFNγ or vehicle control were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. ( D ) IFNγ induces mucus secretion in the absence of infection . URT secretions from uninfected pups treated intranasally with escalating doses of IFNγ (10 ng/μL, 1 ng/μL, 0.1 ng/μL) or vehicle, as well as from rPR8-H3N2-infected pups, were collected at 2 dpi. URT lavages collected at 2 dpi were dotted on nitrocellulose and probed with anti-Muc5AC antibody. Signal intensity was normalized to positive control, and fold-change over mock is shown. Median values are indicated. Statistical differences among groups were assessed using the Kruskal–Wallis test. ( E ) IFNγ enhances shedding during rPR8-H1 infection . Index pups infected with 300 PFU of rPR8-H1 received intranasal IFNγ (1 ng/μL/g), IFNβ (1 ng/μL/g) or vehicle beginning 4–6 hpi. Viral titers from day 4 URT lavage (left), cumulative shedding from days 1–4 (middle), and day 4 URT titers from contact pups (right) were quantified by plaque assay. Statistics . Differences between two groups were analyzed using the Mann–Whitney test. Differences among multi-group medians were analyzed by Kruskal–Wallis test. Experiments represent ≥2 independent biological replicates. Significance is denoted as *P < 0.05. Cartoons created with BioRender.com; graphs generated using GraphPad Prism 10.

    Article Snippet: Pups were treated intranasally with IFNγ (R&D Systems, Lot #169049915, Minneapolis, MN, USA) or IFNβ (R&D Systems, #8234-MB-010, Minneapolis, MN, USA) at 10-0.1ng/μL diluted in 0.1% PBS/BSA and intranasally daily for the duration indicated.

    Techniques: Infection, Control, Plaque Assay, Expressing, Quantitative RT-PCR, Positive Control, MANN-WHITNEY, Generated